Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Makivik Corporation is the legal representative of the Inuit of Nunavik, established in 1978 following the James Bay and Northern Quebec Agreement. The corporation manages the compensation funds from the agreement and invests in a wide range of industries to promote the economic and social development of the Nunavik region. Its major holdings include Air Inuit, Canadian North, and various shipping and construction firms. Additionally, Makivik operates the Nunavik Research Centre, which conducts environmental and biological research focused on wildlife health and food safety for Inuit communities. While it engages in scientific monitoring and community health advocacy, it is not a pharmaceutical or biotechnology company focused on drug development. The organization remains a central pillar of the Nunavik economy, reinvesting profits into community programs and infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Makivik Corporation.